Aromasin Tablets: Product Overview
Aromasin is a prescription medicine containing exemestane 25 mg, an aromatase inhibitor used in the treatment of certain types of hormone-sensitive breast cancer in postmenopausal women. For healthcare professionals, pharmaceutical procurement teams, and qualified distributors in the United States, understanding its product specifications and regulatory requirements is essential when evaluating pharmaceutical supply opportunities.
Cordium Pharmaceuticals Pvt Ltd provides a point of contact for professional pharmaceutical enquiries. Product availability, sourcing arrangements, documentation, and eligibility for supply should be confirmed directly with the company before placing an order.
Aromasin 25 mg Tablets: Product Specifications
The following specifications describe the US-listed Aromasin reference product. Buyers should verify the exact manufacturer, packaging, and approved product documentation for any proposed supply.
Brand name: Aromasin
Generic name: Exemestane
Strength: 25 mg
Dosage form: Oral tablet
Drug class: Aromatase inhibitor
Therapeutic category: Oncology
Approved uses: Certain cases of estrogen-receptor-positive early breast cancer and advanced breast cancer in postmenopausal women, as specified in the US prescribing information
Administration: As directed by the prescribing healthcare professional
Regulatory reference: US prescribing information published through DailyMed
Source: Official Aromasin prescribing information.
Why Is Exemestane Prescribed?
Exemestane reduces estrogen production by inhibiting the aromatase enzyme. Since some breast cancers depend on estrogen to grow, reducing estrogen levels can help manage the disease in appropriately selected patients.
Treatment decisions must be made by a qualified healthcare professional. Aromasin is not suitable for every patient, and its use requires appropriate medical supervision.
Safety Information for Buyers and Healthcare Professionals
Common adverse reactions may include hot flashes, joint pain, fatigue, increased sweating, and difficulty sleeping. Exemestane can also reduce bone mineral density over time. The medicine is contraindicated in patients with known hypersensitivity to exemestane or its ingredients.
Healthcare professionals should review the complete prescribing information, including warnings, contraindications, interactions, and monitoring requirements, before prescribing or dispensing the medicine.
Pharmaceutical Supply Enquiries with Cordium Pharmaceuticals Pvt Ltd
For professional buyers evaluating Aromasin or exemestane tablets, due diligence should include verification of the product's marketing authorization, manufacturing source, batch documentation, certificate of analysis, packaging details, and applicable import requirements.
Cordium Pharmaceuticals Pvt Ltd can be contacted to enquire about relevant product information and potential supply arrangements. Any supply to the US market must comply with applicable FDA requirements, including requirements governing product approval, importation, labeling, and distribution. Do not assume that a product is authorized for US sale solely because it is available in another country.
Frequently Asked Questions (FAQs)
1. What is the strength of Aromasin tablets?
The US-listed Aromasin reference product is available as a 25 mg oral tablet.
2. What is the generic name of Aromasin?
Its active ingredient is exemestane, an aromatase inhibitor.
3. What is Aromasin used for?
It is prescribed for specified cases of hormone-sensitive breast cancer in postmenopausal women, according to the approved prescribing information.
4. Can buyers purchase Aromasin tablets in bulk?
Availability and eligibility depend on the supplier, product authorization, buyer qualifications, and applicable regulations. Contact Cordium Pharmaceuticals Pvt Ltd to discuss verified product details and potential supply arrangements.
5. What documents should pharmaceutical buyers verify?
Buyers should confirm applicable authorization records, product specifications, batch-specific quality documents, labeling, and import or distribution permissions before proceeding.
Conclusion
Aromasin 25 mg tablets are an established exemestane-based prescription medicine used in oncology care. For US-focused pharmaceutical procurement, accurate specifications, verified documentation, and regulatory compliance are essential. Contact Cordium Pharmaceuticals Pvt Ltd for further professional enquiries regarding product information and potential supply options.
Aromasin is a prescription medicine containing exemestane 25 mg, an aromatase inhibitor used in the treatment of certain types of hormone-sensitive breast cancer in postmenopausal women. For healthcare professionals, pharmaceutical procurement teams, and qualified distributors in the United States, understanding its product specifications and regulatory requirements is essential when evaluating pharmaceutical supply opportunities.
Cordium Pharmaceuticals Pvt Ltd provides a point of contact for professional pharmaceutical enquiries. Product availability, sourcing arrangements, documentation, and eligibility for supply should be confirmed directly with the company before placing an order.
Aromasin 25 mg Tablets: Product Specifications
The following specifications describe the US-listed Aromasin reference product. Buyers should verify the exact manufacturer, packaging, and approved product documentation for any proposed supply.
Brand name: Aromasin
Generic name: Exemestane
Strength: 25 mg
Dosage form: Oral tablet
Drug class: Aromatase inhibitor
Therapeutic category: Oncology
Approved uses: Certain cases of estrogen-receptor-positive early breast cancer and advanced breast cancer in postmenopausal women, as specified in the US prescribing information
Administration: As directed by the prescribing healthcare professional
Regulatory reference: US prescribing information published through DailyMed
Source: Official Aromasin prescribing information.
Why Is Exemestane Prescribed?
Exemestane reduces estrogen production by inhibiting the aromatase enzyme. Since some breast cancers depend on estrogen to grow, reducing estrogen levels can help manage the disease in appropriately selected patients.
Treatment decisions must be made by a qualified healthcare professional. Aromasin is not suitable for every patient, and its use requires appropriate medical supervision.
Safety Information for Buyers and Healthcare Professionals
Common adverse reactions may include hot flashes, joint pain, fatigue, increased sweating, and difficulty sleeping. Exemestane can also reduce bone mineral density over time. The medicine is contraindicated in patients with known hypersensitivity to exemestane or its ingredients.
Healthcare professionals should review the complete prescribing information, including warnings, contraindications, interactions, and monitoring requirements, before prescribing or dispensing the medicine.
Pharmaceutical Supply Enquiries with Cordium Pharmaceuticals Pvt Ltd
For professional buyers evaluating Aromasin or exemestane tablets, due diligence should include verification of the product's marketing authorization, manufacturing source, batch documentation, certificate of analysis, packaging details, and applicable import requirements.
Cordium Pharmaceuticals Pvt Ltd can be contacted to enquire about relevant product information and potential supply arrangements. Any supply to the US market must comply with applicable FDA requirements, including requirements governing product approval, importation, labeling, and distribution. Do not assume that a product is authorized for US sale solely because it is available in another country.
Frequently Asked Questions (FAQs)
1. What is the strength of Aromasin tablets?
The US-listed Aromasin reference product is available as a 25 mg oral tablet.
2. What is the generic name of Aromasin?
Its active ingredient is exemestane, an aromatase inhibitor.
3. What is Aromasin used for?
It is prescribed for specified cases of hormone-sensitive breast cancer in postmenopausal women, according to the approved prescribing information.
4. Can buyers purchase Aromasin tablets in bulk?
Availability and eligibility depend on the supplier, product authorization, buyer qualifications, and applicable regulations. Contact Cordium Pharmaceuticals Pvt Ltd to discuss verified product details and potential supply arrangements.
5. What documents should pharmaceutical buyers verify?
Buyers should confirm applicable authorization records, product specifications, batch-specific quality documents, labeling, and import or distribution permissions before proceeding.
Conclusion
Aromasin 25 mg tablets are an established exemestane-based prescription medicine used in oncology care. For US-focused pharmaceutical procurement, accurate specifications, verified documentation, and regulatory compliance are essential. Contact Cordium Pharmaceuticals Pvt Ltd for further professional enquiries regarding product information and potential supply options.
Keywords
